Sandbox ID Genitourinary: Difference between revisions
Jump to navigation
Jump to search
Adeel Jamil (talk | contribs) No edit summary |
Gerald Chi- (talk | contribs) mNo edit summary |
||
Line 1: | Line 1: | ||
===Chancroid=== | |||
{{Details-tx|Chancroid medical therapy}} | |||
* '''Chancroid'''<ref name="pmid21160459">{{cite journal| author=Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC)| title=Sexually transmitted diseases treatment guidelines, 2010. | journal=MMWR Recomm Rep | year= 2010 | volume= 59 | issue= RR-12 | pages= 1-110 | pmid=21160459 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21160459 }} </ref> | |||
:* Preferred regimen: [[Azithromycin]] 1 g orally in a single dose {{or}} [[Ceftriaxone]] 250 mg intramuscularly (IM) in a single dose) {{or}} [[Ciprofloxacin]] 500 mg orally twice a day for 3 days {{or}} [[Erythromycin]] base 500 mg orally three times a day for 7 days | |||
:* Ciprofloxacin is contraindicated for pregnant and lactating women. | |||
---- | ---- | ||
===Gonococcal infection=== | |||
{{Details-tx|Gonococcal infection medical therapy}} | |||
:::* | * '''Gonococcal infection'''<ref name="pmid21160459">{{cite journal| author=Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC)| title=Sexually transmitted diseases treatment guidelines, 2010. | journal=MMWR Recomm Rep | year= 2010 | volume= 59 | issue= RR-12 | pages= 1-110 | pmid=21160459 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21160459 }} </ref><ref name="pmid22874837">{{cite journal| author=Centers for Disease Control and Prevention (CDC)| title=Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. | journal=MMWR Morb Mortal Wkly Rep | year= 2012 | volume= 61 | issue= 31 | pages= 590-4 | pmid=22874837 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22874837 }} </ref> | ||
:* '''Uncomplicated Gonococcal Infections of the Cervix, Urethra, and Rectum''' | |||
::* Preferred regimen: [[Ceftriaxone]] 250 mg intramuscularly {{and}} ([[Azithromycin]] 1 g orally as a single dose {{or}} [[Doxycycline]] 100 mg orally twice daily for 7 days) | |||
::* Alternative regimen: [[Cefuroxime]] 1 g orally | |||
:* '''Uncomplicated Gonococcal Infections of the Pharynx''' | |||
::* Preferred regimen: [[Ceftriaxone]] 250 mg IM in a single dose {{and}} ([[Azithromycin]] 1 g orally as a single dose {{or}} [[Doxycycline]] 100 mg orally twice daily for 7 days) | |||
:* '''Gonococcal Conjunctivitis''' | |||
::* Preferred regimen: [[Ceftriaxone]] 1 g IM in a single dose | |||
:* '''Disseminated Gonococcal Infection (DGI)''' | |||
::* Preferred regimen: [[Ceftriaxone]] 1 g IV/IM every 24 hours | |||
::* Alternative regimen: [[Cefotaxime]] 1 g IV every 8 hours {{or}} [[Ceftizoxime]] 1 g IV every 8 hours | |||
::: Note: All of the preceding regimens should be continued for 24-48 hours after improvement begins, at which time therapy can be switched to cefixime 400 mg orally twice daily to complete at least 1 week of antimicrobial therapy. | |||
:* '''Gonococcal Meningitis ''' | |||
::* Preferred regimen: [[Ceftriaxone]] 1-2 g IV every 12 hours for 10-14 days | |||
:* '''Gonococcal Endocarditis''' | |||
::* Preferred regimen: [[Ceftriaxone]] 1-2 g IV every 12 hours for at least 4 weeks | |||
:* Gonococcal Infections Among Infants | |||
::* '''Ophthalmia Neonatorum Caused by N. gonorrhoeae''' | |||
:::* Preferred regimen: [[Ceftriaxone]] 25-50 mg/kg IV or IM in a single dose, not to exceed 125 mg | |||
::* '''DGI and Gonococcal Scalp Abscesses in Newborns''' | |||
:::* Preferred regimen: | |||
Revision as of 18:55, 27 May 2015
Chancroid
- Chancroid[1]
- Preferred regimen: Azithromycin 1 g orally in a single dose OR Ceftriaxone 250 mg intramuscularly (IM) in a single dose) OR Ciprofloxacin 500 mg orally twice a day for 3 days OR Erythromycin base 500 mg orally three times a day for 7 days
- Ciprofloxacin is contraindicated for pregnant and lactating women.
Gonococcal infection
- Uncomplicated Gonococcal Infections of the Cervix, Urethra, and Rectum
- Preferred regimen: Ceftriaxone 250 mg intramuscularly AND (Azithromycin 1 g orally as a single dose OR Doxycycline 100 mg orally twice daily for 7 days)
- Alternative regimen: Cefuroxime 1 g orally
- Uncomplicated Gonococcal Infections of the Pharynx
- Preferred regimen: Ceftriaxone 250 mg IM in a single dose AND (Azithromycin 1 g orally as a single dose OR Doxycycline 100 mg orally twice daily for 7 days)
- Gonococcal Conjunctivitis
- Preferred regimen: Ceftriaxone 1 g IM in a single dose
- Disseminated Gonococcal Infection (DGI)
- Preferred regimen: Ceftriaxone 1 g IV/IM every 24 hours
- Alternative regimen: Cefotaxime 1 g IV every 8 hours OR Ceftizoxime 1 g IV every 8 hours
- Note: All of the preceding regimens should be continued for 24-48 hours after improvement begins, at which time therapy can be switched to cefixime 400 mg orally twice daily to complete at least 1 week of antimicrobial therapy.
- Gonococcal Meningitis
- Preferred regimen: Ceftriaxone 1-2 g IV every 12 hours for 10-14 days
- Gonococcal Endocarditis
- Preferred regimen: Ceftriaxone 1-2 g IV every 12 hours for at least 4 weeks
- Gonococcal Infections Among Infants
- Ophthalmia Neonatorum Caused by N. gonorrhoeae
- Preferred regimen: Ceftriaxone 25-50 mg/kg IV or IM in a single dose, not to exceed 125 mg
- DGI and Gonococcal Scalp Abscesses in Newborns
- Preferred regimen:
References
- ↑ 1.0 1.1 Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC) (2010). "Sexually transmitted diseases treatment guidelines, 2010". MMWR Recomm Rep. 59 (RR-12): 1–110. PMID 21160459.
- ↑ Centers for Disease Control and Prevention (CDC) (2012). "Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections". MMWR Morb Mortal Wkly Rep. 61 (31): 590–4. PMID 22874837.